Taking a medical wearable to the UK
01
The challenge
A listed neurotechnology company had UK regulatory registration for its wearable muscle-sensing device and early pilots, but no UK channel, pricing or clinic-facing proposition.
02
What we did
Alongside XV Capital Advisory, we produced an independent UK market report: where affluence, self-pay demand and premium physiotherapy overlap, the priority locations, a clinic-led route to market and a founding-partner programme, with a phased entry plan and pilot measures.
03
The return
An evidence-led route into the UK that lets the company commit capital one phase at a time.
Published with the client’s agreement. Ask us and we will walk you through the detail.
Got a number like this to move?
Tell us the outcome, the constraint and the date. We will tell you honestly whether we can help.